Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

Non-Interventional Study of the Safe Use of Aerius in Pediatric Patients With Allergic Rhinitis or Chronic Idiopathic Urticaria.

The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.

Pediatric patients aged 1-5 years

Inclusion Criteria:

• Patients with allergic rhinitis or chronic idiopathic urticaria
• Aged 1-5 years old
• Caregiver's consent to participate

Exclusion Criteria:

• Healthy individuals
• Younger or older than the 1-5 year old age range